Clinical and Economic Outcomes After Implementation of a Fidaxomicin Treatment Optimization and Access Pathway at a US Hospital System.

Lauren F McDanielMelissa N WhiteEngels N ObiRose M KohinkeEllen Rachel S LockhartDamian J ChiprianoYiyun ChenNathan A Everson

Published in: Infectious diseases and therapy (2022)

Implementation of the CDI treatment pathway was associated with better clinical outcomes and hospital cost savings. The findings help validate real-world value of fidaxomicin for CDI disease management.

Keyphrases

healthcare
clostridium difficile
primary care
emergency department
adverse drug
combination therapy